Baxion
Screening
Tags
Alerts
Theme
Inmune Bio, Inc.
INMB
·
NASDAQ
·
$1.43
Share Price as of 11/2
·
$38M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/06/26
10-Q
Q1 ended 03/31/26
05/07/26
10-K
FY 2025
03/30/26
10-Q
Q3 ended 09/30/25
10/30/25
10-Q
Q2 ended 06/30/25
08/07/25
Disclosures
Filter
8-K
Current report
10/29/26
8-K
Current report
10/21/26
8-K
Current report
09/14/26
8-K
Current report
07/31/26
8-K
Current report
07/01/26
Prospectuses and Registrations
Filter
424B5
Prospectus supplement
10/29/26
424B5
Prospectus supplement
12/19/25
424B5
Prospectus supplement
06/30/25
S-8
Registration of securities for employees
06/16/25
S-8
Registration of securities for employees
06/16/25
Proxies
Filter
DEF 14A
Definitive proxy
04/23/26
DEF 14A
Definitive proxy
10/14/25
PRE 14A
Preliminary proxy
10/03/25
DEFR14A
Definitive proxy (revised)
05/09/25
DEFA14A
Additional proxy materials
04/25/25
Ownership
Filter
Form 3
Initial insider ownership
09/23/26
Form 4
Insider transaction
09/23/26
Form 4
Insider transaction
09/17/26
Form 3
Initial insider ownership
09/16/26
Form 4
Insider transaction
07/07/26
Other
Filter
8-A12B/A
8-A12B/A
12/08/25
8-A12B/A
8-A12B/A
12/09/24
EFFECT
Request for effectiveness
08/07/24
CORRESP
Correspondence with the SEC
08/05/24
CORRESP
Correspondence with the SEC
08/01/24
Latest Filings
Filter
8-K
Current report
10/29/26
424B5
Prospectus supplement
10/29/26
8-K
Current report
10/21/26
8-K
Current report
09/14/26
10-Q
Q2 ended 06/30/26
08/06/26
Ownership
Filter
Form 3
Initial insider ownership
09/23/26
Form 4
Insider transaction
09/23/26
Form 4
Insider transaction
09/17/26
Form 3
Initial insider ownership
09/16/26
Form 4
Insider transaction
07/07/26